Guanidine hydrochloride inhibits Hsp104 activity in vivo: a possible explanation for its effect in curing yeast

G Jung1, D C Masison

  • 1Building 8, Room 407, Laboratory of Biochemistry and Genetics, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0851, USA.

Insights

Guanidine hydrochloride (Gdn-HCl) cures yeast prions by inhibiting the Hsp104 protein. This study reveals Gdn-HCl reduces Hsp104

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Yeast Genetics

Background:

  • Yeast prions, like the [PSI+] element, are self-propagating protein aggregates.
  • Guanidine hydrochloride (Gdn-HCl) is commonly used to eliminate yeast prions, but the mechanism is unclear.
  • Hsp104 is a crucial chaperone protein involved in yeast prion replication and stability.

Purpose of the Study:

  • To elucidate the biochemical mechanism by which Gdn-HCl cures yeast prions.
  • To investigate the effect of Gdn-HCl on the function of the Hsp104 protein in vivo.

Main Methods:

  • Yeast cell culture with varying concentrations of Gdn-HCl.
  • Assessment of Hsp104-mediated thermotolerance (basal and acquired).
  • In vivo refolding assay using thermally denatured luciferase.
  • Quantification of Hsp104 protein levels via Western blotting.

Main Results:

  • Gdn-HCl treatment significantly reduced Hsp104-mediated thermotolerance.
  • Gdn-HCl impaired Hsp104's ability to restore denatured luciferase activity.
  • Hsp104 protein abundance remained unaffected by Gdn-HCl exposure.
  • Gdn-HCl was found to inhibit Hsp104 activity in vivo.

Conclusions:

  • Guanidine hydrochloride inhibits the essential chaperone activity of Hsp104 within yeast cells.
  • The prion-curing effect of Gdn-HCl is attributed to its inhibition of Hsp104.
  • This finding provides a biochemical basis for the use of Gdn-HCl in prion elimination studies.